Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |